Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Ovarian Neoplasms 8Breast Neoplasms 6Neoplasm Metastasis 5Carcinoma, Non-Small-Cell Lung 5Stomach Neoplasms 3Neoplasms 3Colonic Neoplasms 3Triple Negative Breast Neoplasms 2Recurrence 2Melanoma 2Lung Neoplasms 2Solid Tumors 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Nervous System Neoplasms 1Locally Advanced Rectal Cancer 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Central Nervous System Diseases 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Brain Metastases From Non-small Cell Lung Cancer 1Brain Diseases 1Advanced Solid Tumors 1

Interventions

gadobenic acid 2XENP 1595 2Cancer Vaccines 2Adjuvants, Immunologic 2veliparib 1interferon gamma-1b 1glutathione pegylated liposomal doxorubicin 1gadoteridol 1elacestrant 1abemaciclib 1Trastuzumab 1Temozolomide 1RAD1901 1Oncolytic Virotherapy 1Interferon-gamma 1Immunotherapy 1Craniotomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Central Nervous System Diseases × veliparib × Clear all
NCT00649207 2017-11-21

A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases

AbbVie

Phase 1 Completed
80 enrolled
CNS

Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, Neoplasm Metastasis, Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡